Encephalitis News and Research

Latest Encephalitis News and Research

Algal metabolites as novel drugs against viruses

A new review article published in the Journal of Biotechnology has provided information on various nutraceutical metabolites extracted from algae.

29 Mar 2022

Climate change may push the US toward the ‘goldilocks zone’ for West Nile virus

Michael Keasling of Lakewood, Colorado, was an electrician who loved big trucks, fast cars, and Harley-Davidsons. He'd struggled with diabetes since he was a teenager, needing a kidney transplant from his sister to stay alive.

28 Mar 2022

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

A recent study investigated the disease severity of SARS-CoV-2 Omicron BA.2 infection among Hong Kong children.

28 Mar 2022

Researcher wins three NIH grants to tackle mosquito-borne viruses

West Nile virus, Usutu virus, Zika virus, and St. Louis encephalitis virus are all transmitted by mosquitoes and cause a significant threat to human health.

23 Mar 2022

INTEGRA’s ASSIST PLUS pipetting robot helps to streamline sample pooling for arbovirus testing

INTEGRA Biosciences’ ASSIST PLUS pipetting robot is helping the Arbovirus Testing Lab at the New Hampshire Public Health Laboratories in Concord, USA, to streamline sample pooling for West Nile and Eastern equine encephalitis virus testing.

From INTEGRA Biosciences 23 Mar 2022

U of U Health researchers lead a $22-million nationwide clinical trial for rare brain disorder

University of Utah Health researchers are leading a five-year, $22-million nationwide clinical trial for NMDA receptor encephalitis––a type of autoimmune encephalitis that prompts the immune system to mistakenly attack the brain, causing confusion, memory loss, seizures, and symptoms similar to bipolar disorder and other psychiatric conditions.

1 Mar 2022

Pathogens in pneumonia-associated respiratory samples from Wuhan prior to SARS-CoV-2 emergence

An interesting paper in PLoS Pathogens describes the broad situation with respect to respiratory pathogens that cause acute respiratory infection (ARI) and pneumonia in the city.

21 Feb 2022

Structural protein vimentin facilitates SARS-CoV-2 entry into endothelial cells

Researchers suggest that extracellular vimentin may act as a coreceptor to allow for SARS-CoV-2 entry into cells.

14 Feb 2022

Looking into the long-COVID brain

Neurological issues, ranging from memory lapses to trouble with attention, have been widely reported after recovery from severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection. Unfortunately, there is limited information about pathways to recovery after severe COVID hospitalization. Now, a prospective study of 4,491 patients hospitalized with COVID suggests neurological recovery can take at least a year. The study is currently available on the medRxiv* preprint while awaiting peer review.

13 Feb 2022

Study tests efficacy of molnupiravir against SARS-CoV-2 VOCs in various animal models

A study published on the bioRxiv* preprint server evaluates molnupiravir against a panel of relevant VOCs using three efficacy models: primary human airway epithelium organoids, a ferret model of upper respiratory disease, and a Roborovski dwarf hamster model for severe COVID-19.

9 Feb 2022

Study links COVID-19 inflammatory manifestations in brain lysates to Alzheimer’s Disease markers

In a new study, researchers investigated a link between the body’s inflammatory response to SARS-CoV-2 infection within the neuropathological pathways and tau hyperphosphorylation.

7 Feb 2022

Cerebrovascular impairment persists months after severe acute COVID-19, UK study

Researchers in the United Kingdom have conducted an observational cohort study on hospitalized patients and have found that the degree of severity of acute coronavirus disease 2019 (COVID-19) predicts the occurrence of chronic cerebrovascular impairment. The study further suggests that the levels of cerebrovascular impairment are associated with worse cognitive, mental, and physical well-being.

7 Feb 2022

Encephalitis News and Research

Latest Encephalitis News and Research

Algal metabolites as novel drugs against viruses

Climate change may push the US toward the ‘goldilocks zone’ for West Nile virus

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

Researcher wins three NIH grants to tackle mosquito-borne viruses

INTEGRA’s ASSIST PLUS pipetting robot helps to streamline sample pooling for arbovirus testing

U of U Health researchers lead a $22-million nationwide clinical trial for rare brain disorder

Pathogens in pneumonia-associated respiratory samples from Wuhan prior to SARS-CoV-2 emergence

Structural protein vimentin facilitates SARS-CoV-2 entry into endothelial cells

Looking into the long-COVID brain

Study tests efficacy of molnupiravir against SARS-CoV-2 VOCs in various animal models

Study links COVID-19 inflammatory manifestations in brain lysates to Alzheimer’s Disease markers

Cerebrovascular impairment persists months after severe acute COVID-19, UK study

Zika virus vaccine candidate found to be safe and effective in preclinical animal studies

Vaccine hypersensitivity in children

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

Study identifies cellular receptors for alphaviruses shared across mosquitoes, humans, and animals

The effect of COVID-19 on routine immunizations for vaccine-preventable diseases

Pediatric hospital admissions rise with omicron SARS-CoV-2 variant

Insight into COVID-19 brain complications

Industry Focus: Cell & Gene Therapy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Encephalitis News and Research

Latest Encephalitis News and Research

Industry Focus: Cell & Gene Therapy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in